Interwell Health Appoints Dr. Carney Taylor as CMO to Enhance Value-Based Kidney Care
- Interwell Health, part of Fresenius Medical Care, appoints Dr. Carney Taylor as Chief Medical Officer to enhance kidney care.
- Dr. Taylor aims to empower nephrologists and improve patient outcomes through innovative, value-based strategies at Interwell Health.
- Interwell Health focuses on supporting nephrologists with resources to thrive in delivering high-quality, patient-centered kidney care.
Interwell Health Appoints Dr. Carney Taylor as Chief Medical Officer to Advance Value-Based Kidney Care
Interwell Health, a prominent entity in value-based kidney care and part of Fresenius Medical Care AG & Co. KGaA, announces the appointment of Dr. Carney Taylor, MD, MBA, as its new chief medical officer (CMO). This strategic move follows the retirement of Dr. George Hart, the former CMO, who will remain with the organization in an advisory capacity. Dr. Taylor's extensive experience in nephrology, spanning over 25 years, positions him as a strong leader to enhance Interwell's clinical strategy and drive initiatives aimed at improving physician engagement and care quality. His previous role as associate CMO and board member enables him to leverage his insights to further the company's mission.
Dr. Taylor emphasizes the importance of collaboration among nephrologists as essential to shaping Interwell's clinical direction. Currently, the organization partners with a network of 2,300 nephrologists who are crucial in implementing its innovative value-based care model. Dr. Taylor's leadership is expected to bolster these efforts by fostering a supportive environment for clinicians. His previous experience co-leading Eastern Nephrology Associates, one of the first practices to engage with Interwell and a significant participant in the federal value-based kidney care program, provides him with a unique perspective on the challenges and opportunities in this sector.
Under Dr. Taylor's stewardship, Interwell Health aims to expand its reach and enhance its innovative strategies to accommodate the growing population of kidney disease patients. The healthcare landscape is shifting, with payers increasingly favoring sustainable, physician-led approaches for managing high-risk patient populations. Dr. Taylor asserts that the secret to Interwell's success lies in empowering clinicians, which not only improves patient outcomes but also optimizes cost management for payers. By focusing on data-driven methodologies and utilizing specialized electronic health records, Interwell Health is committed to elevating patient care standards while also enhancing the practice experience for nephrologists.
In related developments, Interwell Health remains at the forefront of reshaping kidney care through its value-based model. The organization is dedicated to ensuring that nephrologists have the necessary resources and support to thrive in a complex healthcare environment.
As the company moves forward, the leadership transition marks a significant step in its ongoing commitment to delivering high-quality, patient-centered kidney care, setting a benchmark for the industry.
Related Cashu News

HCA Healthcare Raises $3 Billion in Senior Unsecured Notes to Enhance Financial Flexibility
HCA Healthcare successfully completes a public offering of senior unsecured notes totaling US$3.00 billion. This significant move reflects the company’s commitment to bolstering financial flexibility…

IDEXX Laboratories Board Members Show Confidence Through Stock Option Exercises Amid Market Challenges
IDEXX Laboratories (Ticker: IDXX) demonstrates a strong commitment to its future growth as recent insider stock transactions reflect the confidence of its board members. On May 14, several board membe…

Centene Announces Leadership Changes to Strengthen Medicaid and Medicare Operations
Centene Corporation (Ticker: CNC) announces major leadership shifts aimed at boosting its Medicaid and Medicare sectors. These changes could positively impact the company’s strategic direction and ope…

Accuray Partners with University of Wisconsin to Advance Innovative Cancer Therapy Technologies
Accuray Incorporated (Ticker: ARAY) forges a significant decade-long partnership with the University of Wisconsin School of Medicine and Public Health to revolutionize personalized cancer care through…